{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:42:57Z","timestamp":1793324577529,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bpobgyn.2017.08.011","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T02:46:09Z","timestamp":1504665969000},"page":"95-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Clinical implications of the interaction between HPV and HIV infections"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0769-8408","authenticated-orcid":false,"given":"Greta","family":"Dreyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.011_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/sti.75.1.3","article-title":"From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection","volume":"75","author":"Fleming","year":"1999","journal-title":"Sex Transm Infect"},{"issue":"10","key":"10.1016\/j.bpobgyn.2017.08.011_bib2","doi-asserted-by":"crossref","first-page":"e1001","DOI":"10.1371\/journal.pone.0001001","article-title":"Sexual risk factors for HIV infection in early and advanced HIV epidemics in Sub-Saharan Africa: systematic overview of 68 epidemiological studies","volume":"2","author":"Chen","year":"2007","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.011_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/COH.0b013e32833a8844","article-title":"Contribution of sexually transmitted infections to the sexual transmission of HIV","volume":"5","author":"Ward","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.08.011_bib4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/sextrans-2011-050346","article-title":"Association of genital human papillomavirus infection with HIV acquisition: a systematic review and meta-analysis","volume":"89","author":"Lissouba","year":"2013","journal-title":"Sex Transm Infect"},{"issue":"17","key":"10.1016\/j.bpobgyn.2017.08.011_bib5","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1097\/QAD.0b013e328358d908","article-title":"Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis","volume":"26","author":"Houlihan","year":"2012","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.011_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/infdis\/jiw094","article-title":"The association between cervical human papillomavirus infection and subsequent HIV acquisition in Tanzanian and Ugandan women: a nested case-control study","volume":"214","author":"Gallagher","year":"2016","journal-title":"J\u00a0Infect Dis"},{"issue":"11","key":"10.1016\/j.bpobgyn.2017.08.011_bib7","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/infdis\/jit035","article-title":"Human papillomavirus clearance among males is associated with HIV acquisition and increased dendritic cell density in the foreskin","volume":"207","author":"Tobian","year":"2013","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.bpobgyn.2017.08.011_bib8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/ajcp\/102.6.768","article-title":"Immunological events in regressing genital warts","volume":"102","author":"Coleman","year":"1994","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.08.011_bib9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/jid.2009.266","article-title":"Loss of epidermal Langerhans cells occurs in human papillomavirus alpha, gamma, and mu but not beta genus infections","volume":"130","author":"Leong","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.08.011_bib10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.tim.2010.12.006","article-title":"Mucosal junctions: open doors to HPV and HIV infections?","volume":"19","author":"Herfs","year":"2011","journal-title":"Trends Microbiol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2017.08.011_bib11","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1365-2133.2010.09968.x","article-title":"Deregulation of E-cadherin by human papillomavirus is not confined to high-risk, cancer-causing types","volume":"163","author":"Leong","year":"2010","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.011_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/infdis\/jis299","article-title":"Impact of human immunodeficiency virus on the natural history of human papillomavirus genital infection in South African men and women","volume":"206","author":"Mbulawa","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.bpobgyn.2017.08.011_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000355964","article-title":"Host responses to infection with human papillomavirus","volume":"45","author":"Stanley","year":"2014","journal-title":"Curr Probl Dermatol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.08.011_bib14","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.virol.2008.12.022","article-title":"Structure, attachment and entry of polyoma- and papillomaviruses","volume":"384","author":"Sapp","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.bpobgyn.2017.08.011_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-9378-5-19","article-title":"HPV-immune response to infection and vaccination","volume":"5","author":"Stanley","year":"2010","journal-title":"Infect Agent Cancer"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.08.011_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/CMR.05028-11","article-title":"Epithelial cell responses to infection with human papillomavirus","volume":"25","author":"Stanley","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.011_bib17","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/jama.2012.5664","article-title":"Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection","volume":"308","author":"Keller","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.011_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/1471-0528.12015","article-title":"MACH-1 Study Group. Characteristics of HPV infection over time in European women who are HIV-1 positive","volume":"120","author":"Heard","year":"2013","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.011_bib19","first-page":"579","article-title":"The interaction between human immunodeficiency virus and human papillomaviruses in heterosexuals in Africa","volume":"4","author":"Williamson","year":"2015","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.bpobgyn.2017.08.011_bib20","series-title":"The role of human papillomavirus infection and highly active anti-retroviral therapy in cervical disease in HIV infected women","author":"Sang","year":"2012"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.08.011_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/infdis\/jit181","article-title":"Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women","volume":"208","author":"Blitz","year":"2013","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.08.011_bib22","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/infdis\/jit170","article-title":"Natural history of anal vs oral HPV infection in HIV-infected men and women","volume":"208","author":"Beachler","year":"2013","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.bpobgyn.2017.08.011_bib23","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/CEJ.0b013e3282f75ea1","article-title":"HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy","volume":"17","author":"De Vuyst","year":"2008","journal-title":"Eur J Cancer Prev"},{"issue":"11","key":"10.1016\/j.bpobgyn.2017.08.011_bib24","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/infdis\/jit090","article-title":"Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women","volume":"207","author":"Konopnicki","year":"2013","journal-title":"J\u00a0Infect Dis"},{"issue":"11","key":"10.1016\/j.bpobgyn.2017.08.011_bib25","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/infdis\/jit374","article-title":"Risk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with men","volume":"208","author":"Schwartz","year":"2013","journal-title":"J\u00a0Infect Dis"},{"issue":"11","key":"10.1016\/j.bpobgyn.2017.08.011_bib26","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/infdis\/jiw038","article-title":"HLA immunogenotype determines persistent human papillomavirus virus infection in HIV-infected patients receiving antiretroviral treatment","volume":"213","author":"Meys","year":"2016","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.08.011_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.03.030","article-title":"Risk factors for abnormal anal cytology over time in HIV-infected women","volume":"207","author":"Baranoski","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.011_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.clinre.2013.07.002","article-title":"Immunity and squamous cell carcinoma of the anus: epidemiological, clinical and therapeutic aspects","volume":"38","author":"Pernot","year":"2014","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.08.011_bib29","doi-asserted-by":"crossref","first-page":"F32","DOI":"10.1016\/j.vaccine.2012.07.092","article-title":"The burden of human papillomavirus infections and related diseases in Sub-Saharan Africa","volume":"31","author":"De Vuyst","year":"2013","journal-title":"Vaccine"},{"issue":"Pt 12","key":"10.1016\/j.bpobgyn.2017.08.011_bib30","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1099\/vir.0.020669-0","article-title":"Influence of human immunodeficiency virus and CD4 count on the prevalence of human papillomavirus in heterosexual couples","volume":"91","author":"Mbulawa","year":"2010","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.bpobgyn.2017.08.011_bib31","series-title":"Cervical neoplasia in women with and without HIV-related immune depletion: epidemiology and pathogenesis related to HPV types","author":"Van Aardt","year":"2016"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.08.011_bib32","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1080\/20742835.2013.11441218","article-title":"Human papilloma virus-type distribution in South African women without cytological abnormalities: a peri-urban study","volume":"5","author":"Van Aardt","year":"2013","journal-title":"South Afr J Gynaecol Oncol"},{"issue":"12","key":"10.1016\/j.bpobgyn.2017.08.011_bib33","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J\u00a0Infect Dis"},{"issue":"18","key":"10.1016\/j.bpobgyn.2017.08.011_bib34","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/01.aids.0000253361.63578.14","article-title":"HPV and HIV Study Group. Human papillomavirus types among women infected with HIV: a meta-analysis","volume":"20","author":"Clifford","year":"2006","journal-title":"AIDS"},{"issue":"18","key":"10.1016\/j.bpobgyn.2017.08.011_bib35","doi-asserted-by":"crossref","first-page":"8085","DOI":"10.7314\/APJCP.2015.16.18.8085","article-title":"HPV infection and cervical abnormalities in HIV positive women in different regions of Brazil, a middle-income country","volume":"16","author":"Freitas","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.bpobgyn.2017.08.011_bib36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fonc.2014.00048","article-title":"Distribution of human papillomavirus genotypes among HIV-positive and HIV-negative women in Cape Town, South Africa","volume":"4","author":"McDonald","year":"2014","journal-title":"Front Oncol"},{"issue":"Suppl. 2","key":"10.1016\/j.bpobgyn.2017.08.011_bib37","first-page":"893","article-title":"Management of HPV-related cancer risk in women with HIV\/AIDS","volume":"19","author":"Petse","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.bpobgyn.2017.08.011_bib38","doi-asserted-by":"crossref","first-page":"617","DOI":"10.7196\/SAMJ.2016.v106i6.10335","article-title":"Oncogenic and incidental HPV types associated with histologically confirmed cervical intraepithelial neoplasia in HIV-positive and HIV-negative South African women","volume":"106","author":"Van Aardt","year":"2016","journal-title":"South Afr Med J"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.08.011_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.09.086","article-title":"Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women","volume":"214","author":"Massad","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.011_bib40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/path.3970","article-title":"One virus, one lesion - individual components of CIN lesions contain a specific HPV type","volume":"227","author":"Quint","year":"2012","journal-title":"J\u00a0Pathol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2017.08.011_bib41","doi-asserted-by":"crossref","first-page":"E946","DOI":"10.1002\/ijc.27532","article-title":"Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16","volume":"131","author":"Van der Marel","year":"2012","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.08.011_bib42","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/IGC.0000000000000422","article-title":"Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection","volume":"25","author":"Van Aardt","year":"2015","journal-title":"Int J Gynecol Cancer"},{"issue":"Suppl. 5","key":"10.1016\/j.bpobgyn.2017.08.011_bib43","doi-asserted-by":"crossref","first-page":"F168","DOI":"10.1016\/j.vaccine.2012.06.045","article-title":"Human papillomavirus, human immunodeficiency virus and immunosuppression","volume":"30","author":"Denny","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.08.011_bib44","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1046\/j.1525-1438.2001.01022.x","article-title":"Invasive cervical cancer and human immunodeficiency virus (HIV) infection: a South African perspective","volume":"11","author":"Moodley","year":"2001","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.011_bib45","first-page":"142","article-title":"Screening for human papillomavirus-associated cervical disease in HIV-infected women","volume":"23","author":"Keller","year":"2015","journal-title":"Top Antivir Med"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.08.011_bib46","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0090-8258(90)90077-X","article-title":"Human immunodeficiency virus infection and cervical neoplasia","volume":"38","author":"Maiman","year":"1990","journal-title":"Gynecol Oncol"},{"issue":"9581","key":"10.1016\/j.bpobgyn.2017.08.011_bib47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.bpobgyn.2017.08.011_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163965","article-title":"Epidemiology of HPV genotypes among HIV positive women in Kenya: a systematic review and meta-analysis","volume":"11","author":"Menon","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.08.011_bib49","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/QAI.0000000000001113","article-title":"Effect of HIV infection on human papillomavirus types causing invasive cervical cancer in Africa","volume":"73","author":"Clifford","year":"2016","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.bpobgyn.2017.08.011_bib50","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/ijc.28425","article-title":"Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa","volume":"134","author":"Denny","year":"2014","journal-title":"Int J Cancer"},{"issue":"15","key":"10.1016\/j.bpobgyn.2017.08.011_bib51","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archinternmed.2010.253","article-title":"Spectrum of cancer risk late after AIDS onset in the United States","volume":"170","author":"Simard","year":"2010","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.bpobgyn.2017.08.011_bib52","first-page":"947","article-title":"Outcome of treated anogenital intraepithelial neoplasia among human immunodeficiency virus-infected women","volume":"53","author":"Dedes","year":"2008","journal-title":"J\u00a0Reprod Med"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.011_bib53","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/AOG.0b013e31821a0f4d","article-title":"Genital warts and vulvar intraepithelial neoplasia: natural history and effects of treatment and human immunodeficiency virus infection","volume":"118","author":"Massad","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.08.011_bib54","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ajog.2015.03.034","article-title":"HPV-related disorders in women: a systematic review","volume":"213","author":"Stier","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.bpobgyn.2017.08.011_bib55","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1128\/JCM.37.10.3316-3322.1999","article-title":"Detection of multiple human papillomavirus types in Condylomata Acuminata lesions from otherwise healthy and immunosuppressed patients","volume":"37","author":"Brown","year":"1999","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.08.011_bib56","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/infdis\/jit191","article-title":"Consistent condom use reduces the genital human papillomavirus burden among high-risk men: the HPV infection in men study","volume":"208","author":"Pierce Campbell","year":"2013","journal-title":"J\u00a0Infect Dis"},{"issue":"8","key":"10.1016\/j.bpobgyn.2017.08.011_bib57","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3851\/IMP1890","article-title":"The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection","volume":"16","author":"Marais","year":"2011","journal-title":"Antivir Ther"},{"issue":"5996","key":"10.1016\/j.bpobgyn.2017.08.011_bib58","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool","year":"2010","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.08.011_bib59","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S1470-2045(14)70481-4","article-title":"Present status of human papillomavirus vaccine development and implementation","volume":"16","author":"Herrero","year":"2015","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.08.011_bib60","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","article-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis","volume":"15","author":"Drolet","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"48","key":"10.1016\/j.bpobgyn.2017.08.011_bib61","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1016\/j.vaccine.2013.09.032","article-title":"Safety and immunogenicity of the HPV-16\/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study","volume":"31","author":"Denny","year":"2013","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.bpobgyn.2017.08.011_bib62","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/infdis\/jit657","article-title":"Comparison of the immunogenicity and reactogenicity of Cervarix and Gardasil human papillomavirus vaccines in HIV-infected adults: a randomized, double-blind clinical trial","volume":"209","author":"Toft","year":"2014","journal-title":"J\u00a0Infect Dis"},{"issue":"43","key":"10.1016\/j.bpobgyn.2017.08.011_bib63","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1016\/j.vaccine.2014.08.011","article-title":"Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescents and young adults","volume":"32","author":"Giacomet","year":"2014","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.011_bib64","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cid\/ciw354","article-title":"Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience","volume":"63","author":"Garland","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bpobgyn.2017.08.011_bib65","unstructured":"WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. World Health Organization 2013. http:\/\/apps.who.int\/iris\/bitstream\/10665\/94830\/1\/9789241548694_eng.pdf Accessed 8 Aug 2017."},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.011_bib66","doi-asserted-by":"crossref","first-page":"e53494","DOI":"10.1371\/journal.pone.0053494","article-title":"Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa","volume":"8","author":"Firnhaber","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.011_bib67","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/QAD.0000000000000512","article-title":"Combination antiretroviral therapy reduces the detection risk of cervical human papilloma virus infection in women living with HIV","volume":"29","author":"Zeier","year":"2015","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.011_bib68","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000325079","article-title":"Diverse and high prevalence of human papillomavirus associated with a significant high rate of cervical dysplasia in human immunodeficiency virus\u2013infected women in Johannesburg, South Africa","volume":"53","author":"Firnhaber","year":"2009","journal-title":"Acta Cytol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.011_bib69","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ijc.29353","article-title":"Cervical cancer screening in sub-Saharan Africa: a randomized trial of VIA versus cytology for triage of HPV-positive women","volume":"137","author":"Bigoni","year":"2015","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.bpobgyn.2017.08.011_bib70","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/ijc.28616","article-title":"Lower cost strategies for triage of human papillomavirus DNA-positive women","volume":"134","author":"Qiao","year":"2014","journal-title":"Int J Cancer"},{"issue":"14","key":"10.1016\/j.bpobgyn.2017.08.011_bib71","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.bpobgyn.2017.08.011_bib72","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/jnci\/djq342","article-title":"Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial","volume":"102","author":"Denny","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.bpobgyn.2017.08.011_bib73","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1111\/j.1582-4934.2012.01631.x","article-title":"Changes in type-specific human papillomavirus load predict progression to cervical cancer","volume":"16","author":"Depuydt","year":"2012","journal-title":"J\u00a0Cell Mol Med"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.011_bib74","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pvr.2015.05.002","article-title":"Performance of the Xpert HPV assay in women attending for cervical screening","volume":"1","author":"Cuzick","year":"2015","journal-title":"Papillomavirus Res"},{"issue":"16","key":"10.1016\/j.bpobgyn.2017.08.011_bib75","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1097\/QAD.0b013e32833e163e","article-title":"Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women","volume":"24","author":"Kuhn","year":"2010","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.bpobgyn.2017.08.011_bib76","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/1471-0528.12655","article-title":"Meta-analysis of the efficacy of cold coagulation as a treatment method for cervical intraepithelial neoplasia: a systematic review","volume":"121","author":"Dolman","year":"2014","journal-title":"BJOG"},{"issue":"S24","key":"10.1016\/j.bpobgyn.2017.08.011_bib77","first-page":"868","article-title":"Type specific hrHPV persistence after treatment of HGSIL in a high-risk population","volume":"24","author":"Mojaki","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2017.08.011_bib78","first-page":"380","article-title":"A\u00a0systematic review of radiotherapy capacity in low- and middle-income countries","volume":"4","author":"Grover","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.bpobgyn.2017.08.011_bib79","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/610876","article-title":"Complications of common gynecologic surgeries among HIV-Infected women in the United States","volume":"2012","author":"Penman-Aguilar","year":"2012","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.08.011_bib80","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/20742835.2015.1083697","article-title":"The impact of HIV infection on women receiving radiation for cervical cancer","volume":"7","author":"Mangena","year":"2015","journal-title":"South Afr J Gynaecol Oncol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.08.011_bib81","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/IGC.0000000000000441","article-title":"HIV Status and acute hematologic toxicity among patients with cervix cancer undergoing radical chemoradiation","volume":"25","author":"Simonds","year":"2015","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.011_bib82","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s00259-013-2671-9","article-title":"Differentiation of HIV-associated lymphoma from HIV-associated reactive adenopathy using quantitative FDG PET and symmetry","volume":"41","author":"Mhlanga","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.011_bib83","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/20742835.2013.11441202","article-title":"A\u00a0retrospective analysis comparing clinical staging with magnetic resonance imaging staging in patients with cervical cancer","volume":"5","author":"Sauer","year":"2013","journal-title":"South Afr J Gynaecol Oncol"},{"key":"10.1016\/j.bpobgyn.2017.08.011_bib84","series-title":"Poster session presented at: 8th african organisation for research and training in cancer conference; cairo, Egypt","article-title":"Postoperative complications in HIV infected patients undergoing radical hysterectomy for early stage cervical cancer, and the variables to predict those","author":"Herbst","year":"2011"},{"issue":"9","key":"10.1016\/j.bpobgyn.2017.08.011_bib85","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/cam4.485","article-title":"Optimal management of cervical cancer in HIV-positive patients: a systematic review","volume":"4","author":"Ntekim","year":"2015","journal-title":"Cancer Med"},{"issue":"11","key":"10.1016\/j.bpobgyn.2017.08.011_bib86","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/cncr.26639","article-title":"Completion of and early response to chemoradiation among human immunodeficiency virus (HIV)-positive and HIV-negative patients with locally advanced cervical carcinoma in South Africa","volume":"118","author":"Simonds","year":"2012","journal-title":"Cancer"},{"issue":"31","key":"10.1016\/j.bpobgyn.2017.08.011_bib87","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1200\/JCO.2016.67.9613","article-title":"HIV infection and survival among women with cervical cancer","volume":"34","author":"Dryden-Peterson","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.08.011_bib88","first-page":"24","article-title":"The severity and optimal management of iron deficiency and anaemia before radiation for cervical cancer at the University of Pretoria Academic Hospitals","volume":"9","author":"Dreyer","year":"2017","journal-title":"South Afr J Gynaecol Oncol"},{"key":"10.1016\/j.bpobgyn.2017.08.011_bib89","series-title":"Abstract presented at 15th biennial meeting of the international gynaecological cancer society","first-page":"8","article-title":"Treatment and outcome of late stage vulva cancer at the pretoria academic hospital complex, South Africa","author":"Mnisi","year":"2014"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.08.011_bib90","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/infdis\/jir813","article-title":"CD4+ cell count and HIV load as predictors of size of anal warts over time in HIV-infected women","volume":"205","author":"Luu","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.bpobgyn.2017.08.011_bib91","series-title":"Treatment for advanced vulvar cancer. Presentation at the South African society of clinical & radiation oncology (SASCRO) and South African society of medical oncology (SASMO) congress","first-page":"4","author":"Thomas","year":"2017"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693417301293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693417301293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T04:36:15Z","timestamp":1602909375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693417301293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":91,"alternative-id":["S1521693417301293"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.08.011","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical implications of the interaction between HPV and HIV infections","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}